SMi Groups' 17th annual Parallel Trade conference returns to London next February. Use the early bird and save £300

1. BOOK BY
31ST OCTOBER
AND SAVE £300
BOOK BY
28TH NOVEMBER
AND SAVE £100
SMi Presents the 9th Annual Conference on… 9 - 10
FEB
2015
Parallel Trade
Improve patient safety by addressing the
implementation and best practices of parallel trade
Holiday Inn Regents Park Hotel, London, UK
“Informative and provocative conference. Well run, well
chaired and good networking opportunities” Delegate 2014
Eric Noehrenberg,
Director, Regional Market Access Lead, Shire GmbH
KEY SPEAKERS INCLUDE:
• Mike Isles, Executive Director, European Alliance for Access to Safe
Medicines
• Prof. Bertram Häussler, Chairman of the Board of Management, IGES
• Janice Haigh, Practice Leader, Market Access, Quintiles
• John Jolley, Founder, Pharma Consult Europe Ltd
• Antonio Mendonca Alves, CEO, MD Pharma SA
• Dermot Glynn, Senior Adviser, Europe Economics
• Leyla Hannbeck Chief Pharmacist, NPA
• Chris Stothers, Partner, Arnold and Porter
...plus many more
BUSINESS BENEFITS FOR 2015:
• HEAR from true industry leaders in the field of Parallel Trade, and listen
to the latest from IGES on the influencing factors affecting the market
• ENHANCE supply chain protection and patient safety with an
update on the Falsified Medicines Directive
• BENEFIT from case study sessions on best practices and
implementation from a Chief Pharmacist and Wholesaler
• JOIN ROUND TABLE DISCUSSIONS on the future of Parallel Trade will
generate debate, don’t miss out!
Parallel Trade for Accession States
Assessing the Problems
Workshop Leader: Martin Paltnoi, Senior Consultant,
@SMIPHARM
CHAIR FOR 2015:
PLUS TWO INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPS
Wednesday 11th February 2015, Holiday Inn Regents Park Hotel, London, UK
Parallel Trade – Management Strategies
Workshop Leader: Janice Haigh, Practice Leader,
Market Access, Quintiles
8.30am – 12.30pm
www.parallel-trade.com
BOOK BY 31ST OCTOBER TO RECEIVE £300 OFF
BOOK BY 28TH NOVEMBER TO RECEIVE £100 OFF
MPA Business Services Ltd
1.30pm – 5.30pm
Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711

2. 9th Annual Parallel Trade
Day One | Monday 9th February 2015
8.30 Registration & Coffee
9.00 Chairman's Opening Remarks
Eric Noehrenberg, Director, Regional Market Access Lead, Shire
GmbH
PRICING, GENERICS & STAKEHOLDER ENGAGEMENT
USA 3%
Middle East 4%
Register online at: www.parallel-trade.com • Alternatively fax yo
OPENING ADDRESS
9.10 Overview of Parallel Trade and its Impact
•What is parallel trade?
•Who benefits from parallel trade? Where are negative impacts
of parallel trade?
•Key players in parallel trade and their respective strategies
•Meeting the challenges of parallel trade
Eric Noehrenberg, Director, Regional Market Access
Lead, Shire GmbH
9.50 Session Reserved for EAEPC
Speaker and presentation to be confirmed
10.30 Morning Coffee
11.00 Assessing pricing strategies for parallel trade
•Price strategy, price competition and equity – defending
differential pricing
•Understanding the role of price strategy in parallel trade
management
•What are the other options?
Janice Haigh, Practice Leader, Market Access,
Quintiles
KEYNOTE ADDRESS
11.40 Initiatives of Parallel Distributors in the context
of Falsified Medicines Directive
•Good Parallel Distribution Guidelines
•Early Warning Anti-CF Platform
•Joint Audits Initiative
•European Medicines Verification Organization
Tomasz Dzitko, Founder and CEO, Delfarma
12.20 Networking Lunch
1.30 Parallel Trade in Germany – Situation and perspective
•Parallel importation dynamics – assessing the impact
•The evaluation of new drugs in Germany – new paradigm
for Parallel Trade?
•Political and regulatory environment: What`s changed,
what is to be expected
Prof. Bertram Häussler, Chairman of the Board of
Management, IGES Institut GmbH
2.10 The Impact and Future of Parallel Trade
•UK Parallel Trade vs Eastern Europe
•The impact of Parallel Trade on the consumer
•Pharmacy registered Wholesalers vs Pharmaceutical
wholesalers
•Effects of market awareness between countries
Patrick O’Neill-Ortiz, Managing Director, Parallel
Pharma Ltd
2.50 Afternoon Tea
CASE STUDY SESSION – BEST PRACTICE AND IMPLEMENTATION
3.20 Case Study: The role of the pharmacists in parallel trade defined
•Distribution and supportive programme with the pharmacists
as the central person
•Channels and factors with regulations, market access and
other factors
•Sourcing parallel trade when they’re cheaper and how it’s
impacting the pharmacists
Leyla Hannbeck, Chief Pharmacist, NPA
4.00 The future of parallel imports within the EU
•The importance of free market economics
•Required regulatory framework
•Medical devices insight
Shan Hassam, Group Director, Veenak International Ltd.
4.40 Chairman's Closing Remarks and Close of Day One
Who should attend this conference:
You should attend this event if you work in the Parallel
Trade sector of the Pharmaceutical Industry with
responsibilities in Supply Chain, Market Access, Global
Pricing, Generics and Stakeholder Engagement.
Job titles include:
• Head of Supply Chain
• Practice Leaders
• Head of Market Access
• Pharmacists
and Global Pricing
• Planning Managers
• Head of Parallel Trade
• Lawyers
• Head of European Trade
• Attorneys
• Head of Distribution
2013/14 Parallel Trade
Attendees by Region:
UK 40%
Europe excluding UK 53%
SPONSORSHIP AND EXHIBITION OPPORTUNITIES
SMi offer sponsorship, exhibition, advertising
and branding packages, uniquely tailored to
complement your company’s marketing
strategy. Prime networking opportunities exist
to entertain, enhance and expand your
client base within the context of an
independent discussion specific to your
industry.
Should you wish to join the increasing number
of companies benefiting from sponsoring our
conferences please call:
Alia Malick on +44 (0) 20 7827 6168 or
email: amalick@smi-online.co.uk

3. 9th Annual Parallel Trade
Day Two | Tuesday 10th February 2015
•Assessing the impact of parallel trade on certain countries
•Concerns about medicines shortages to lower priced
countries
•Competition law – an overview of what’s likely
to happen over the next five years to impact
parallel trade
Suzanne Elvidge, Specialised Writer, Healthcare,
Pharmaceuticals and Business
11.40 Effects of parallel trade on affordable access to medicines
1.30 Intellectual Property Update
2.10 Patient Safety – Fighting the Fakes
2.50 Afternoon Tea
3.20 Government intervention in exporting countries, a new trend?
4.00 A clear divide still stands - The Big Debate!
4.40 Chairman’s Closing Remarks and Close of Day Two
Supported by
8.30 Registration & Coffee
9.00 Chairman's Opening Remarks
Eric Noehrenberg, Director, Regional Market Access Lead,
Shire GmbH
THE IMPACT OF PARALLEL TRADE
KEYNOTE ADDRESS
9.10 EU perspective for Parallel Trade
9.50 Supply chain protection and patient safety
•Assessing the security of supply chain to
enhance patient safety
•Evaluating the complexity of European supply
chain
•Reviewing what the hurdles ahead may be
John Jolley, Founder, Pharma Consult Europe Ltd
10.30 Morning Coffee
11.10 Market Outlook and Macro Dynamics
•Developments in last decade
•Impact on patient and manufacturer
Dr Shabnam Hanassab, Senior Consultant,
IMS Health
in the EU
•Effects on prices
•Effects on timing of launch
•Effects on reliability of supply
•Effects on innovation
Dermot Glynn, Senior Adviser, Europe Economics
12.20 Networking Lunch
FALSIFIED MEDICINES & PATIENT SAFETY
KEYNOTE ADDRESS
•Can brand names be changed in parallel trade? Recent
case law
•Specific Mechanism - the Advocate General’s Opinion?
•Other recent developments
•Practical implications
Christopher Stothers, Partner,
Arnold & Porter (UK) LLP
•The evolving internet rogue pharmacy environment
•Law enforcement and collaborative voluntary actions
•Addressing the issue of online demand by patients
Mike Isles, Executive Director, European Alliance
for Access to Safe Medicines
THE FUTURE OF PARALLEL TRADE
•Examples of government intervention is exporting countries
•Are governments trying to restrict exports?
Is this legitimate?
•Are there alternatives?
Antonio Mendonca Alves, CEO, MD Pharma SA
ROUND TABLE DISCUSSION
•Ethics of Parallel Trade and the Originators
•Input and perspective on what the ethics of parallel trade
and the originators are
•Greece as a target – is ring fencing in place or will it be?
•Is parallel trade justified – different perspectives
Leaders:
Antonio Mendonca Alves, CEO, MD Pharma SA
Tomasz Dzitko, Founder and CEO, Delfarma
Want to know how you can get involved? Interested in promoting your services to this market?
Contact Sarah Watson, SMi Marketing on +44 (0) 207 827 6134 or email: swatson@smi-online.co.uk
our registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711

4. HALF-DAY POST-CONFERENCE AM WORKSHOP
Wednesday 11th February 2015
8.30am – 12.30pm
Holiday Inn Regents Park Hotel, London, UK
A: Parallel Trade - Management Strategies
Workshop Host:
Janice Haigh, Practice Leader, Market Access, Quintiles
Overview of the workshop
Following feedback from SMi’s Parallel Trade Conferences
in 2013 and 2014 and a further masterclass in July 2013,
this sell-out workshop will again run alongside our 2015
conference. Parallel Trade continues to bring challenges
to pharmaceutical manufacturers: challenges including
logistics and supply, challenges of accurate
measurement and of motivating affiliates in import and
export markets, challenges around revenue and profit
and challenges of ensuring patient supply. This workshop
is designed to help you address these challenges by
providing advice based on real experience. The
workshop agenda will review the available strategic
options including pricing and supply management and
will give clear recommendations. Ample time will be
allowed for questions and discussion.
Programme
08.30 Registration and Coffee
09.00 Welcome and introductions
09.15 Background to parallel trade
09.30 PT management options
09.50 An overview of supply management
10.20 Coffee Break
10.50 Critical success factors
11.20 Review of tactical details
12.00 Discussion and Q&A
12.30 End of Workshop
About the workshop host:
Janice Haigh, Practice Leader,
Market Access, Europe
• Joined Quintiles Consulting in January 2012 as
Practice Leader for Market Access in Europe
• From 2006 to December 2011, Senior Director
Pricing and Market Access for Astellas Pharma Europe
• Responsible for development and implementation of
pricing and market access strategy for new and in-market
products, working closely with brand teams and affiliates
• Responsible for all price management, analysing effect
of price changes on other markets
• Designed, implemented and managed Astellas’s supply
chain integrity program which ensured the matching of
supply and demand of products in Europe
• Before joining Astellas in 2006, Janice worked in
consultancy for 20 years, including almost 10 years at
IMS Health/Cambridge Pharma Consultancy
Responsible for leading projects involving pricing, parallel
trade, health economics and health policy. Clients
included European and global pharmaceutical
companies but also trade associations and government
bodies such as the European Commission
About the Organisation:
Quintiles (NYSE: Q) is the world’s largest provider of
biopharmaceutical development and commercial
outsourcing services with a network of more than 29,000
employees conducting business in approximately 100
countries. We have helped develop or commercialize all
of the top-50 best-selling drugs on the market. Quintiles
applies the breadth and depth of our service offerings
along with extensive therapeutic, scientific and analytics
expertise to help our customers navigate an increasingly
complex healthcare environment as they seek to
improve efficiency and effectiveness in the delivery of
better healthcare outcomes. To learn more about
Quintiles, please visit www.quintiles.com.

5. HALF-DAY PRE-CONFERENCE PM WORKSHOP
Wednesday 11th February 2015
1.30pm - 5.30pm
Holiday Inn Regents Park Hotel, London, UK
B: Parallel Trade for Accession States
Assessing the Problems
Workshop Host: Martin Paltnoi, Senior Consultant,
MPA Business Services Ltd
Overview of workshop:
This workshop will look to give an overview and insight
into the interpretation of the specific mechanisms
from both an originator’s perspective and a parallel
trader’s perspective. The importance of Parallel
Trade from the Accession States will be discussed in
addition to other matters likely to affect the parallel
trade from Accession States.
Programme:
1.30 Registration and Coffee
2.00 Introduction and Overview
- Interpretation of the Specific Mechanism:
a) From the originators perspective
b) From the parallel traders view
2.30 How important is parallel trade from Accession
States
3.00 What is the view of parallel trade from Accession
States in the post-Specific Mechanism
3.30 Coffee Break
4.00 Review of the Specific Mechanism as it
appears in the Accession Treaty and as a result
of subsequent court action
What are the differences in the different
Accession States likely to influence the Specific
Mechanism and Parallel Trade from those states.
5.00 Discussion and Q&A
- Other matters likely to effect the parallel trade
from Accession States, i.e. the need to
upgrade MAs filed prior to 2008 (Croatia)
(Appendix to Annex V - Accession Treaty).
5.30 End of Workshop
About the workshop host:
Martin Paltnoi is the Chief Executive of MPA
which was created in 1973 after spending
many years as a professional market
researcher involved mainly, but not exclusively,
in providing business intelligence for pharmaceutical
and healthcare industries on a national and
international level.
A qualified statistician and economist, was first introduced
to pharmaceuticals when invited to be included in
the small team to set up to provide audits for
pharmaceuticals by IMS in 1959/1960. After that
introduction to the market, spent a number of years in a
market research capacity in leading manufacturing
companies where the results of research into business
intelligence have been applied. Since 1973, he has been
supplying a business intelligence service for the industry
and is probably best known for his and his company’s
work in pharmaceutical patents. This has also included
providing a patent intelligence service for the parallel
trade industry sector. As such he has become a noted
expert in related matters like the Specific Mechanism,
covering trade from the Accession States.
About the Organisation:
MPA’s has built a reputation as one of the leading
business intelligence experts in the pharmaceutical
sector. MPA’s consultancy work is intended to seek out
and provide business intelligence on any aspect related
to pharmaceutical and healthcare matters (on both a
national and international basis). From competitive
intelligence to legal and pharmaceutical information,
sales and marketing to demographic and cultural
enquiries, MPA addresses any questions that are posed
relating to marketing and corporate strategic planning
in pharmaceuticals and healthcare. To learn more
about MPA, please visit www.mpasearch.co.uk

6. PARALLEL TRADE
Conference: Monday 9th & Tuesday 10th February 2015, Holiday Inn Regents Park Hotel, London, UK Workshop: Wednesday 11th February 2015, London
4 WAYS TO REGISTER
FAX your booking form to +44 (0) 870 9090 712
PHONE on +44 (0) 870 9090 711
www.parallel-trade.com
POST your booking form to: Events Team, SMi Group Ltd, 2nd Floor
South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, UK
Unique Reference Number
Our Reference LVP-128
DELEGATE DETAILS
Please complete fully and clearly in capital letters. Please photocopy for additional delegates.
Title: Forename:
Surname:
Job Title:
Department/Division:
Company/Organisation:
Email:
Company VAT Number:
Address:
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
Mobile:
Switchboard:
Signature: Date:
I agree to be bound by SMi's Terms and Conditions of Booking.
ACCOUNTS DEPT
Title: Forename:
Surname:
Email:
Address (if different from above):
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
VENUE Holiday Inn Regents Park Hotel Carburton Street, London, W1W 5EE
□ Please contact me to book my hotel
Alternatively call us on +44 (0) 870 9090 711,
email: hotels@smi-online.co.uk or fax +44 (0) 870 9090 712
Terms and Conditions of Booking
Payment: If payment is not made at the time of booking, then an invoice will be issued and must be
paid immediately and prior to the start of the event. If payment has not been received then credit
card details will be requested and payment taken before entry to the event. Bookings within 7 days
of event require payment on booking. Access to the Document Portal will not be given until payment
has been received.
Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another
delegate to take your place at any time prior to the start of the event. Two or more delegates may
not ‘share’ a place at an event. Please make separate bookings for each delegate.
Cancellation: If you wish to cancel your attendance at an event and you are unable to send a
substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing
that cancellation is made in writing and received at least 28 days prior to the start of the event.
Regretfully cancellation after this time cannot be accepted. We will however provide the
conferences documentation via the Document Portal to any delegate who has paid but is unable
to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to
provide documentation in these circumstances. We cannot accept cancellations of orders placed
for Documentation or the Document Portal as these are reproduced specifically to order. If we have
to cancel the event for any reason, then we will make a full refund immediately, but disclaim any
further liability.
Alterations: It may become necessary for us to make alterations to the content, speakers, timing,
venue or date of the event compared to the advertised programme.
Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection
Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other
products and services. Unless you tick here □we may also share your data with third parties offering
complementary products or services. If you have any queries or want to update any of the data that
we hold then please contact our Database Manager databasemanager@smi-online.co.uk or visit
our website www.smi-online.co.uk/updates quoting the URN as detailed above your address on the
attached letter.
□ Book by 31st October 2014 to receive £300 off the conference price
□ Book by 28th November 2014 to receive £100 off the conference price
EARLY BIRD
DISCOUNT
CONFERENCE PRICES
I would like to attend: (Please tick as appropriate) Fee Total
□ Conference & 2 Workshops £2697.00 + VAT £3236.40
□ Conference & 1 Workshop AM □ PM □ £2098.00 + VAT £2517.60
□ Conference only £1499.00 + VAT £1798.80
□ 1 Workshop only AM □ PM □ £599.00 + VAT £718.80
□ 2 Workshops £1198.00 + VAT £1437.60
PROMOTIONAL LITERATURE DISTRIBUTION
□ Distribution of your company’s promotional
literature to all conference attendees £999.00 + VAT £1198.80
The conference fee includes refreshments, lunch, conference papers, and access to the
Document Portal. Presentations that are available for download will be subject to
distribution rights by speakers. Please note that some presentations may not be available
for download. Access information for the document portal will be sent to the e-mail
address provided during registration. Details are sent within 24 hours post conference.
DOCUMENTATION
I cannot attend but would like to purchase access to the following Document
Portal/paper copy documentation Price Total
□ Access to the conference documentation
on the Document Portal £499.00 + VAT £598.80
□ The Conference Presentations – paper copy £499.00 - £499.00
(or only £300 if ordered with the Document Portal)
PAYMENT
Payment must be made to SMi Group Ltd, and received before the event, by one of
the following methods quoting reference P-128 and the delegate’s name. Bookings
made within 7 days of the event require payment on booking, methods of payment
are below. Please indicate method of payment:
□ UK BACS Sort Code 300009, Account 00936418
□ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU
Swift (BIC): LOYDGB21013, Account 00936418
IBAN GB48 LOYD 3000 0900 9364 18
□ Cheque We can only accept Sterling cheques drawn on a UK bank.
□ Credit Card □ Visa □ MasterCard □ American Express
All credit card payments will be subject to standard credit card charges.
Card No: □□□□ □□□□ □□□□ □□□□
Valid From □□/□□ Expiry Date □□/□□
CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Cardholder’s Name:
Signature: Date:
I agree to be bound by SMi's Terms and Conditions of Booking.
Card Billing Address (If different from above):
VAT
VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on live
Streaming, on Demand, Document portal and literature distribution for all UK customers and
for those EU Customers not supplying a registration number for their own country here.
______________________________________________________________________________________________
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email events@smi-online.co.uk